// App-Quantinova.ai

: Dermatologic Adverse Events in Acute Myeloid Leukemia Patients Treated with IDH Inhibitors Ivosidenib and Enasidenib

Researchers

Presenter

  • Rose Parisi

Principal Investigators

  • Joseph Stoll

  • Haoling Zhu

  • Stephen Dusza

  • Melissa Pulitzer

  • Eytan Stein

  • Alina Markova

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Albany Medical Center, Albany, NY

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Peripheral Nervous System

Disease

  • Acute myelocytic leukemia

  • Peripheral neuropathy

  • Bacterial Skin Infection

  • Solid malignancies

Biomarkers

  • Isocitrate dehydrogenase 1

  • Isocitrate dehydrogenase 2

Drug/Treatment

  • Enasidenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved